Zobrazeno 1 - 10
of 76
pro vyhledávání: '"W. Dornoff"'
Autor:
Kleinsasser O
Publikováno v:
Laryngo- rhino- otologie [Laryngorhinootologie] 1991 Jan; Vol. 70 (1), pp. 49-53.
Autor:
O, Kleinsasser
Publikováno v:
Laryngo- rhino- otologie. 70(1)
Autor:
O Kleinsasser
Publikováno v:
Laryngo-Rhino-Otologie. 70:49-50
Autor:
Thomas B. Brunner, Thomas Hehr, H. Schmidberger, H J Feldmann, R Aurisch, Susanne Martina Eschmann, G Holl, E Henze, Wolfgang Schäfer, Matthias Miederer, M Tosch, Andreas Küsters, Carl-Martin Kirsch, Günther Gademann, C Herold, M Beck, Tanja Schimek-Jasch, M Schreckenberger, M. Tosch, Ursula Nestle, Jochem König, A Amthauer, S M Eschmann, Michael Mix, Felix Momm, H. Christian Rischke, Peter Hass, R Baum, R Pötter, T Hehr, Y. Bultel, C La Fougere, Eleni Gkika, S Ezzidin, R Bares, H Annweiler, L Trampert, R Freiherr von Gumppenberg, Th. Krause, Anca-Ligia Grosu, B Siekmeyer, M L Sautter-Bihl, Stephanie Kremp, W Brenner, Andrea Schaefer-Schuler, W Oehler, Jochen Fleckenstein, A Hertel, W Dornoff, U Lützen, Karin Dieckmann, H Hoffmanns, G Stüben, W Alberti, B Kimmig, J Ricke, D Aebersold, K Tatsch, Wolfgang Weber, K Strehle, Anca L. Grosu, Guido Hildebrandt, Philipp T. Meyer, M Pech, Alexander Thieme, M Schwaiger, J Sciuk, M Piroth, Volker Budach, Gabriele Holl, M. Stockinger, U Freund, I Schlöcker, J Dunst, Bernd J. Krause, Christian Rübe, Joachim Widder, Sonja Adebahr, Daniel Zips, M Bamberg
Publikováno v:
The Lancet Oncology. 21:581-592
Summary Background With increasingly precise radiotherapy and advanced medical imaging, the concept of radiotherapy target volume planning might be redefined with the aim of improving outcomes. We aimed to investigate whether target volume reduction
Publikováno v:
Oncology Research and Treatment. 22:140-144
Summary Purpose: Fractionated cisplatin-containing regimens are routinely used for chemotherapy of certain types of cancer. Dolasetron has been shown to be effective i
Autor:
R. Zschaber, W. Schultze, P. Reitzig, B. Knutzen, G.J. Wiedemann, Johannes Drach, Kurt Possinger, G. Herzog, B. Kilpert, Peter Reichardt, N. Zojer, Michael Stahl, B. Kaluza, S. Hansen, F.A. Muthny, Clemens Unger, A. Dietzmann, H. Merz, W. Dornoff, Tahar Benhidjeb, R. Stecker, K. Mross, E. Richter, T. Wagner, Hannes Kaufmann, Elke Jäger, Michael Fiegl, D. Uthgenannt, R. Seeger, Peter M. Schlag, B. Brockmann, Mathias Freund, Susanna Hegewisch-Becker, A.A. Fauser, Alfred C. Feller, V. Briese, T. Feyerabend, H.J. Illiger, K. Mücke, J. Nowicki, B. Rodi, J.H. Hartlapp, O. Löwenstrom, Stefan Fuxius, K. Weber
Publikováno v:
Oncology Research and Treatment. 22:85-91
Autor:
Rolf A. Stahel, Karin Mattson, N. v. Walree, K. Liippo, Joachim von Pawel, Peter Drings, P. Kellokumpu-Lehtinen, Christian Manegold, W. W. ten Bokkel-Huinink, C. Sederholm, S. Ricci, Gunnar Wagenius, B. Bergman, W. Dornoff, Assad Chemaissani
Publikováno v:
Annals of Oncology. 8:525-529
Summary Background This randomised study was designed to determine the response rate, survival and toxicity of single-agent gemcitabine and cisplatin-etoposide in chemo-naive patients with locally advanced or metastatic non-small-cell lung cancer. Pa
Autor:
Dirk G. Kieback, Annette Hasenburg, M. Ziller, J. Kuck, T. Menschik, P. Hadji, H.W. Tessen, W. Dornoff, F. Melchert
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 20(7)
Background: Adjuvant treatment of hormone receptor-positive breast cancer in postmenopausal women with aromatase inhibitors may be associated with increased bone loss. Patients and methods: Two hundred patients were randomised to receive exemestane o
Autor:
Thomas Zwingers, H. J. Staiger, H. Radtke, E. Terhardt, W. Gassmann, P. Meusers, Eva Lengfelder, Hubert J. Stein, H. H. Gerhartz, T. Wagner, C. Schöber, F. Ludwig, Karl Lennert, M. G. Willems, Michael Hallek, W. Dornoff, W. Hettchen, Eckhard Thiel, Wolfgang Siegert, I. Meuthen, W. Enne, Markus Tiemann, M. Thomas, R. Kuse, J. Heise, Dieter Huhn, C. Schadeck, N. Brack, Wolfgang Wilmanns, K. Kabelitz, M. Engelhard, Günter Brittinger, E. Schumacher
Publikováno v:
Annals of Oncology. 2:177-180
In a prospective multicenter trial the efficiency of the response-adapted COP-BLAM/IMVP-16 protocol to induce complete remissions (CR) in high-grade malignant non-Hodgkin’s lymphomas as well as the prognostic relevance of adjuvant radiotherapy were
Autor:
P. Reitzig, Kurt Possinger, T. Feyerabend, Clemens Unger, E. Richter, Susanna Hegewisch-Becker, A.A. Fauser, G.J. Wiedemann, W. Schultze, T. Wagner, Hannes Kaufmann, K. Mross, F.A. Muthny, Alfred C. Feller, Johannes Drach, Peter Reichardt, O. Löwenstrom, D. Uthgenannt, R. Seeger, N. Zojer, H. Merz, S. Hansen, W. Dornoff, B. Rodi, K. Mücke, B. Kilpert, B. Knutzen, J.H. Hartlapp, Mathias Freund, A. Dietzmann, B. Kaluza, R. Stecker, Michael Fiegl, J. Nowicki, H.J. Illiger, Peter M. Schlag, Tahar Benhidjeb, B. Brockmann, Michael Stahl, Stefan Fuxius, K. Weber, G. Herzog, Elke Jäger, R. Zschaber, V. Briese
Publikováno v:
Oncology Research and Treatment. 22:154-156
SummaryUm Leitlinien fur die adjuvante Therapie bei Kolon- und Rektumkarzinom zu erstellen, haben Vertreter der CAO, der AIO und der ARO am 11. 03.1994 einen Konsens erarbeitet; dieser wu